Nanogen/Becton Dickinson joint venture awarded first US patent:
This article was originally published in Clinica
The Nanogen/Becton Dickinson Partnership, a joint venture established between the two companies in 1997, has been granted a US patent for a technique that can simplify the amplification and detection of target nucleic acid sequences on a bioelectronic chip, thereby lowering costs. The technique, known as ligation dependent strand displacement amplification, was developed by Becton Dickinson and is used on Nanogen's NanoChip cartridge. It is designed to increase the level of automation and ease of use of the NanoChip system, Nanogen said.